close
close

Positive 8-week body weight results from Lexaria’s GLP-1 diabetes animal study

Positive 8-week body weight results from Lexaria’s GLP-1 diabetes animal study

KELOWNA, BC / ACCESSWIRE / August 22, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces that it has received a new initial public offering …